Predicting neoadjuvant therapy response in breast cancer from preoperative biopsy via spatial-semantic-differential learning and interpretable clinicopathological-guided fusion
AI analyzing tumor tissue predicts which breast cancer patients will completely respond to pre-surgery chemotherapy.
This AI model predicts pathological complete response to neoadjuvant therapy in breast cancer from preoperative biopsies. It uses a novel spatial-semantic fusion approach with clinicopathological interpretation.
What the study was
- Study design
- Model development and validation
- Population
- Breast cancer patients undergoing neoadjuvant therapy
- Category
- Diagnostics
- Maturity
- Exploratory
- Journal
- Medical Image Analysis
Why it surfaced
Novel AI approach for breast cancer treatment prediction. Published in high-impact imaging journal. Exploratory stage.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.